BNTX
USDBioNTech SE American Depositary Share
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$104.320
Máximo
$107.000
Mínimo
$104.215
Volume
0.13M
Fundamentos da empresa
Capitalização de mercado
25.2B
Setor
Biotecnologia
País
Germany
Estatísticas de negociação
Volume médio
0.85M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
HC Wainwright & Co. Maintains Buy on BioNTech, Raises Price Target to $140
HC Wainwright & Co. analyst Robert Burns maintains BioNTech with a Buy and raises the price target from $136 to $140.
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from early to late disease stagesDemonstrated encouraging
BioNTech to Host Innovation Series R&D Day on November 11, 2025
MAINZ, Germany, October 28, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (NASDAQ:BNTX, "BioNTech" or "the Company")), will host an edition of the Company's Innovation Series R&D Day at 09:00 a.m. Eastern Standard Time (3:00
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (NASDAQ:BNTX, "BioNTech" or "the Company")) will announce its financial results for the third quarter 2025 on Monday, November 3, 2025. Additionally, the
JP Morgan Maintains Neutral on BioNTech, Lowers Price Target to $120
JP Morgan analyst Jessica Fye maintains BioNTech with a Neutral and lowers the price target from $121 to $120.
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech's next milestone in the execution of its oncology
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.